by Asa Elmore | Sep 21, 2020 | Events, News, Press Releases
Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC SOUTH SAN FRANCISCO, Calif., Sept. 21, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company today announced that it has been...
by Asa Elmore | Sep 17, 2020 | Events, Presentations
Sutro Biopharma Presents at World ADC 2020 – PowerPoint Presentation To download the World ADC presentation by Arturo Molina, MD, MS, Chief Medical Officer, CLICK HERE To download the World ADC presentation by Trevor Hallam, Ph.D., Chief Scientific Officer,...
by Asa Elmore | Sep 15, 2020 | Events, Presentations
Cantor Fitzgerald Virtual Heathcare Conference 2020 – PowerPoint Presentation To download the presentation, Click...
by Asa Elmore | Sep 9, 2020 | Events, News, Presentations, Press Releases
Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting Updated Data Further Demonstrate Promising Efficacy and Safety Profile in a Heavily Pretreated Patient Population Not Selected Based on...
by Asa Elmore | Sep 3, 2020 | Events, News, Presentations, Press Releases
Sutro Biopharma to Present at Two Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Sept. 3, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein...
by Asa Elmore | Sep 2, 2020 | Events, News, Presentations, Press Releases
Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting Ongoing Data Further Demonstrate Promising Efficacy and Safety Profile in a Heavily Pretreated Patient Population Not...
